Hucog 5000IU HCG (Liquid)

Hucog 5000IU HCG (Liquid)

  • $50.00



PRODUCT CLASSIFICATION Glycoprotein hormones, alpha polypeptide
RECOMMENDED DOSAGE 500-3000 IU, administered 1-3 times per week
RISK OF ACNE Possible
WATER RETENTION None
HBR No
RISK OF HEPATOTOXICITY None
AROMATIZATION None
MANUFACTURER Bharat Serums And Vaccines
WAREHOUSE LOCATION International Warehouse 1
ACTIVE SUBSTANCE Human Chorionic Gonadotropin

IMPORTANT: This product is available in liquid form!

Introducing HUCOG 5000 IU, a powerful injectable medication crafted by Bharat Serums and Vaccines Limited, featuring Human Chorionic Gonadotropin (hCG) as its key active ingredient. hCG is a naturally occurring hormone produced during pregnancy, primarily secreted by the developing placenta. One of its prominent uses is to suppress appetite and promote the body?s ability to utilize fat for energy. Additionally, hCG is widely recognized for its role in inducing ovulation, treating female infertility, and enhancing sperm production in men. Bodybuilders also leverage its benefits during steroid cycles and post-cycle therapy to facilitate weight loss and elevate testosterone levels.

Athletes and bodybuilders often turn to HUCOG at the end of an anabolic-androgenic steroid cycle to prevent muscle tissue breakdown. This hormone is crucial for restoring normal testicular function, which can be compromised by prolonged anabolic steroid use, leading to testicular shrinkage. HUCOG helps effectively revive testicular size and function. When paired with a very low-calorie diet, athletes can shed unwanted fat while preserving muscle mass. Women may also benefit from using HUCOG alongside a low-calorie regimen to target stubborn fat.

The recommended dosage of HUCOG during a cycle typically ranges from 500 IU to 3000 IU weekly (administered 1-3 times per week). Frequent injections help stabilize blood levels, whereas a single large dose may increase estrogen levels through testosterone aromatization, potentially causing gynecomastia. While some bodybuilders report using up to 6000 IU for six days, this approach carries risks and should be tailored to individual needs. For effective post-cycle therapy, HUCOG is best administered in smaller doses of 250-500 IU daily for 2 to 3 weeks, sufficiently stimulating recovery from testicular atrophy. It is advisable to initiate an hCG cycle for 2 to 3 weeks, allowing at least a month off in between. Incorporating HUCOG towards the end of a steroid cycle, ideally in the final week, can enhance results. It can also be effectively combined with Clomid or Nolvadex during post-cycle therapy, extending treatment beyond the hCG cessation.

Potential serious side effects of HUCOG may include severe pelvic pain, swelling in extremities, abdominal pain and swelling, shortness of breath, weight gain, diarrhea, nausea, or vomiting. Common side effects can include headaches, irritability, mild swelling or water retention, mood changes, and injection site discomfort. In boys, hCG may trigger early signs of puberty, such as voice deepening, pubic hair growth, and increased acne or sweating.